Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease a multicenter retrospective cohort study /
BACKGROUND AND AIMS: Inflammatory bowel disease (IBD) patients with Clostridioides difficile infection (CDI) are at increased risk of adverse outcomes. Data on fidaxomicin use in IBD remains scarce. We assessed the effectiveness and safety of fidaxomicin for CDI and its impact on IBD outcomes in a l...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2025
|
| Sorozat: | JOURNAL OF CROHNS & COLITIS
19 No. 5 |
| Tárgyszavak: | |
| doi: | 10.1093/ecco-jcc/jjaf056 |
| mtmt: | 36076729 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/37501 |